Patents, Spillovers and Competition in Biotechnology

David H. Austin ()

Discussion Papers from Resources For the Future

Abstract: I perform an event study on 600+ patents awarded primarily to 20 leading biotechnology firms and find significant changes in market values at the time of the awards. Adjusting for partial anticipation of events, I estimate that core technology patents in highly contested research areas are expected to generate between $13 and $21 million of economic value. They also generate spillover benefits for the patentee’s rivals—presumably including knowledge transfers—valued at $3 to $6 million per firm. Awardees may appropriate only half of private benefits, although I observe negative spillovers for some high-profile awards. Most patents have no significant market impact.

New Economics Papers: this item is included in nep-cse, nep-ino and nep-tid
Date: 2000-11-01
View list of references

Downloads: (external link)
http://www.rff.org/documents/RFF-DP-00-53.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:rff:dpaper:dp-00-53

Access Statistics for this paper

More papers in Discussion Papers from Resources For the Future
Series data maintained by Webmaster ().